Churchill Capital CFO awarded 420K stock options

Hart Ilan reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hart Ilan reported acquisition or exercise transactions in this Form 4 filing.

Churchill Capital Corp X reported that Chief Financial Officer Ilan Hart received a grant of stock options covering 420,355 shares. The options were awarded for no cash payment and vest over time, with one quarter vesting on October 27, 2026 and the remainder vesting in equal monthly installments thereafter, subject to continued service.

Insider Trade Summary

Grant/Award: 420,355 shares

Grant/Award 1 txn

Insider Hart Ilan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	420,355	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 420,355 contracts (Direct)

Footnotes (1)

1. F1. 1/4th of the shares underlying the option shall vest on October 27, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Churchill Capital Corp X (CCCX) disclose?

Churchill Capital Corp X disclosed that Chief Financial Officer Ilan Hart received a grant of stock options for 420,355 shares. The options were awarded at no cash cost and will vest over time based on his continued service with the company.

How many Churchill Capital (CCCX) stock options were granted to Ilan Hart?

Ilan Hart was granted stock options covering 420,355 shares of Churchill Capital Corp X. This entire amount represents a new derivative award, bringing his total options of this type to 420,355 shares following the reported transaction, according to the Form 4 filing.

When do Ilan Hart’s Churchill Capital (CCCX) options begin vesting?

Ilan Hart’s options begin vesting on October 27, 2026, when one quarter of the underlying shares vest. After that initial vesting date, additional shares vest in equal monthly installments, conditioned on his continued service with Churchill Capital Corp X.

What is the vesting schedule for the 420,355 Churchill Capital (CCCX) options?

The vesting schedule provides that one quarter of the 420,355 underlying shares vests on October 27, 2026. The remaining shares vest in equal monthly installments, with 1/48th of the total vesting each month thereafter, assuming Ilan Hart remains in service.

Did Ilan Hart pay cash to receive the Churchill Capital (CCCX) option grant?

According to the Form 4 data, the stock options were granted with a reported transaction price per derivative of 0.0000. This indicates the award was a compensatory grant rather than a purchase for cash in the open market or through a tender offer.

What type of security did Ilan Hart receive from Churchill Capital (CCCX)?

Ilan Hart received a derivative security described as a stock option (right to buy). This award represents the right to acquire Churchill Capital Corp X shares in the future, subject to the specified vesting schedule and the other terms of the option agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 08:45 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hart Ilan

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE CO 80027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$13.22	02/13/2026		A		420,355		(1)	02/12/2036	Common Stock	420,355	$0	420,355	D

Explanation of Responses:

1. 1/4th of the shares underlying the option shall vest on October 27, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

	/s/ Jason D. Hall, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.